Navigation Links
Pharmaceutical Benefits Scheme Extended for 2 Novel Breast Cancer Drugs

Two new drugs to battle breast cancer have made their way into the Pharmaceutical Benefits Scheme which is a succor for the multitude of sufferers//, who can now avail superior treatment notwithstanding the cost of drugs. This is good news as breast cancer carries the ignominy of being the most common cancer befalling women, affecting 14,000 people annually.

The drugs are targeted at post-menopausal women suffering hormone-dependant early breast cancer, who will be in a position to avail the drug from December 1.

Breast Cancer Network Australia CEO Lyn Swinburne explained that the drugs, called as aromatase inhibitors, were consumed by more than 50% of women suffering breast cancer. Ms Swinburne said "It is important these drugs are on the PBS because they offer women choice. Women shouldn't have to worry about the cost; they have enough decisions to make and options to consider without the added worry of how they are going to pay for these things. What we want is the best treatment for the individual woman to ensure she has the best chance of recovery."

National Breast Cancer Centre acting deputy director Dr Alison Evans said, "Their listing on the PBS is wonderful news as it provides additional treatment options for patients with early breast cancer."


'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Medicis Pharmaceutical company enters pediatric market
4. Pharmaceutical companies are targeting patients
5. FDA approves Watson Pharmaceuticals Oxytrol patch
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
8. Pharmaceutical industries grant for R&D to be monitored
9. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
10. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... Atlanta, GA (PRWEB) , ... ... ... information technology and security executive networking and relationship-marketing firm, announced today that ... for the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy Awareness,” which can ... 6th, sparks a conversation about epilepsy, bearing down on the social stigma and ... be diagnosed with epilepsy within their lifetime. With such a large percentage of ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced that the company will provide alerting technology to Central Illinois Health ... awarded $1.7 million in federal funds as the sole sub-recipient participating with ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one of New ... recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the Waldorf Astoria ... getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for his expertise ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... for the Florida Hospital West Florida Region. McGuinness brings experience in executive leadership ... engaging staff, physicians and leaders. , In her new role, that officially begins ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)...  John Seng, founder of Spectrum Science Communications , announced ... Executive Officer following two consecutive years of high double digit growth ... in 2014 and assumed management of the firm that Seng founded ... as Healthcare Agency of the Year and was selected among the ... ...
(Date:12/5/2016)... Research and Markets has announced the addition of the ... Growth and Demand Forecast to 2022" report to their offering. ... , , ... test market is expected to grow at a CAGR of 4.5% ... is witnessing high growth, due to growing female geriatric population and ...
(Date:12/5/2016)... PharmaBoardroom today releases its new 70 page Switzerland Healthcare ... , ... policymakers, and stakeholders crucial insight into Switzerland ; a ... to some of the world,s most important international health institutions as well ... with a number one ranking globally in terms of ease of doing ...
Breaking Medicine Technology: